Commentary on “Apabetalone, a BET protein inhibitor, inhibits kidney damage in diabetes by preventing pyroptosis via modulating the P300/H3K27ac/PLK1 axis”

• Kaiqing Li,
• Xue Xia,
• Tong Fu,
• Ying Tong

Affiliations

Kaiqing Li

Heilongjiang University of Chinese Medicine, Harbin, China

Xue Xia

Heilongjiang University of Chinese Medicine, Harbin, China

Tong Fu

Brandeis University, Waltham, MA, United States

Ying Tong

Corresponding author.; First Affiliated Hospital, Heilongjiang University of Chinese Medicine, Harbin, China